Reply by Authors
J Urol
.
2020 Jun;203(6):1155.
doi: 10.1097/JU.0000000000000746.03.
Epub 2020 Mar 16.
Authors
Mounsif Azizi
1
,
Ahmet M Aydin
1
,
Ali Hajiran
1
,
Andrew Lai
2
,
Ambuj Kumar
3
,
Charles C Peyton
1
,
Suks Minhas
4
,
Guru P Sonpavde
5
,
Jad Chahoud
1
,
Lance C Pagliaro
6
,
Andrea Necchi
7
,
Philippe E Spiess
1
Affiliations
1
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
2
Department of Urology, University of Illinois at Chicago, Chicago, Illinois.
3
Division of Evidence Based Medicine and Health Outcomes Research, University of South Florida, Tampa, Florida.
4
Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
5
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
6
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
7
Department of Urology and Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
PMID:
32176595
DOI:
10.1097/JU.0000000000000746.03
No abstract available
Publication types
Comment